"Evaluation of the Efficacy of an inTerdialytic Ethanol 40% v/v - enoxapaRin 1000 U/mL Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients"

PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 9, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Tunnelled Hemodialysis Catheter Infection
Interventions
DRUG

Ethanol

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

DRUG

enoxaparin

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

Trial Locations (1)

63003

RECRUITING

CHU Clermont-Ferrand, Clermont-Ferrand

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

CH du Puy en Velay, Hôpital Emile Roux

UNKNOWN

collaborator

University Hospital, Toulouse

OTHER

collaborator

Centre hospitalier de Chambéry

UNKNOWN

collaborator

Calydial

OTHER

collaborator

Hôpital Edouard Herriot

OTHER

collaborator

Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex

UNKNOWN

collaborator

Hôpital Lapeyronie

UNKNOWN

collaborator

Centre de dialyse d'Alès

UNKNOWN

collaborator

University Hospital of Saint-Etienne

OTHER

collaborator

Centre hospitalier de Perpignan

OTHER

collaborator

Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat

UNKNOWN

collaborator

CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER